XML 104 R84.htm IDEA: XBRL DOCUMENT v3.20.4
Geneos Therapeutics, Inc. - Fair Value Assumptions (Details) - Geneos Therapeutics, Inc.
Jun. 01, 2020
USD ($)
Noncontrolling Interest [Line Items]  
Geneos enterprise value $ 4,966,531,000
Expected term (years)  
Noncontrolling Interest [Line Items]  
Equity method investment, measurement input, expected term 2 years 11 months 1 day
Volatility  
Noncontrolling Interest [Line Items]  
Equity method investment, measurement input 0.70
Risk-free interest rate  
Noncontrolling Interest [Line Items]  
Equity method investment, measurement input 0.0246